Calian Group (TSE:CGY) Sets New 12-Month High – Time to Buy?

Shares of Calian Group Ltd. (TSE:CGY) hit a new 52-week high during trading on Thursday . The company traded as high as C$70.80 and last traded at C$70.76, with a volume of 37734 shares changing hands. The stock had previously closed at C$66.15.

Key Stories Impacting Calian Group

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Desjardins lifted their price target on shares of Calian Group from C$59.00 to C$66.00 and gave the company a “buy” rating in a research report on Thursday, November 27th. Ventum Financial raised their target price on shares of Calian Group from C$72.00 to C$82.00 and gave the company a “buy” rating in a research note on Friday. Canaccord Genuity Group lifted their target price on shares of Calian Group from C$63.00 to C$80.00 in a report on Friday. Royal Bank Of Canada upped their price target on Calian Group from C$58.00 to C$60.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, Acumen Capital raised their price objective on Calian Group from C$70.00 to C$85.00 and gave the company a “buy” rating in a research report on Friday. Six research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of C$74.83.

Calian Group Price Performance

The firm’s fifty day simple moving average is C$60.38 and its 200-day simple moving average is C$54.12. The firm has a market capitalization of C$805.62 million, a PE ratio of 40.11, a PEG ratio of 2.50 and a beta of 0.70. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54.

Calian Group (TSE:CGY) last posted its quarterly earnings results on Thursday, February 12th. The company reported C$1.03 EPS for the quarter. Calian Group had a net margin of 1.50% and a return on equity of 3.37%. The firm had revenue of C$208.00 million for the quarter. On average, research analysts forecast that Calian Group Ltd. will post 4.9475219 earnings per share for the current fiscal year.

Calian Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 11th. Shareholders of record on Wednesday, March 11th will be issued a $0.28 dividend. The ex-dividend date of this dividend is Wednesday, February 25th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.6%. Calian Group’s dividend payout ratio (DPR) is presently 63.64%.

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.